In April 2022, 32 of the world’s premier diabetes experts gathered in Barcelona, along with representatives from industry, advocacy, and regulatory bodies, to discuss...

​For the first time, Time in Range was used as the main outcome measured in a clinical trial for a diabetes medication. Read about the study results and implications.

Find out more from experts about the latest advancements in continuous glucose monitoring, ketone monitors, and non-invasive technologies.

The diaTribe team was on-the-ground in Barcelona, Spain to cover the latest news in diabetes technology from the ATTD 2022 international conference. Here are our top...

At this year’s Advanced Technologies and Treatment conference in Barcelona, diaTribe will bring together dozens of experts in diabetes for a revolutionary consensus...

A low carb diet can be difficult to follow, especially for children. Katie Bacon explains several ways in which low carb principles can be adapted to real life

The diaTribe team is excited to cover all the latest news in diabetes technology and treatments, attending our first in-person diabetes conference in over two years!...

Time in Range (TIR) is a well established and easy to use measurement of your daily glucose management. The glycemia risk index (or dysglycemia index) is an emerging...

Time in Range (TIR) is an effective tool to use in your daily diabetes management, but how can you actually spend more of your day in range? Read below for some helpful...

Cherise Shockley shares how she decided to switch from DIY Loop to Control-IQ, and what she learned along the way.

Time in Range (TIR) is more than just another diabetes metric; it is a tool that can be used to improve communication with your healthcare providers and empower you both...

In this video on understanding your ambulatory glucose profile (AGP) report, pediatric endocrinologist, Dr. Amy Criego from the International Diabetes Center, uses real-...

If you just got a continuous glucose monitoring system, you may be wondering how to use it most effectively and how to understand your glucose data. Read our tips,...

Each year, the American Diabetes Association updates its Standards of Care, or recommended diabetes practice guidelines. The document includes recommendations for target...

In a study of children younger than seven, automated insulin delivery (AID) led to greater Time in Range, less Time above Range, and lower A1C levels.

Rybelsus, a GLP-1 agonist pill already approved in the US, received positive feedback from the European Medicines Agency (EMA) in January and was just approved on...

Diabetes and heart disease are closely connected. This article discusses heart disease, important numbers to know, and ways to improve your heart health

Highlights from The diaTribe Foundation and TCOYD panel discussion at ADA 2019

The diaTribe team covers the latest in diabetes technology from the 14th annual ATTD 2021 international conference (set virtually this year). Here are our top highlights...

The American Diabetes Association recommends SGLT-2 inhibitors or GLP-1 agonists for people with heart and kidney problems, the use of Time in Range in diabetes...